BridgeBio Pharma (BBIO) News Today $49.59 +0.72 (+1.47%) Closing price 04:00 PM EasternExtended Trading$49.07 -0.52 (-1.05%) As of 06:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BBIO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period BridgeBio to Participate in September Investor ConferencesAugust 27 at 7:30 AM | globenewswire.comBridgeBio Pharma to Present New Data on Acoramidis at ESC Congress 2025August 25 at 7:51 AM | quiverquant.comQBridgeBio to Present Additional Open-label Extension Data from ATTRibute-CM at ESC Congress 2025August 25 at 7:30 AM | globenewswire.comBridgeBio Pharma (NASDAQ:BBIO) CFO Sells $2,089,886.76 in StockAugust 25 at 4:07 AM | americanbankingnews.com272,506 Shares in BridgeBio Pharma, Inc. $BBIO Purchased by CW Advisors LLCAugust 24 at 7:09 AM | marketbeat.comAmerican Century Companies Inc. Has $35.52 Million Position in BridgeBio Pharma, Inc. $BBIOAugust 24 at 4:08 AM | marketbeat.com175,000 Shares in BridgeBio Pharma, Inc. $BBIO Bought by Monashee Investment Management LLCAugust 23, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) CEO Neil Kumar Sells 26,156 SharesAugust 23, 2025 | insidertrades.comNuveen LLC Buys Shares of 433,112 BridgeBio Pharma, Inc. $BBIOAugust 23, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Stock Price Down 2.1% After Insider SellingAugust 23, 2025 | americanbankingnews.comBrokerages Set BridgeBio Pharma, Inc. (NASDAQ:BBIO) Price Target at $61.35August 22, 2025 | americanbankingnews.comBridgeBio Pharma (NASDAQ:BBIO) CFO Sells $871,641.19 in StockAugust 21, 2025 | marketbeat.comThomas Trimarchi Sells 17,353 Shares of BridgeBio Pharma (NASDAQ:BBIO) StockAugust 20, 2025 | insidertrades.comBridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives Average Recommendation of "Buy" from BrokeragesAugust 20, 2025 | marketbeat.comTD Cowen Reiterates Buy Rating on BridgeBio Pharma (BBIO) on Strong Attruby SalesAugust 20, 2025 | msn.comDruckenmiller's Duquesne adds Warner Bros., exits BridgeBio among Q2 tradesAugust 19, 2025 | msn.comBridgeBio Pharma: Betting Big On Rare Disease CatalystsAugust 19, 2025 | seekingalpha.comCharles Schwab Investment Management Inc. Sells 24,536 Shares of BridgeBio Pharma, Inc. $BBIOAugust 19, 2025 | marketbeat.comBridgeBio Pharma, Inc. (NASDAQ:BBIO) Is Expected To Breakeven In The Near FutureAugust 18, 2025 | finance.yahoo.comInvesco Ltd. Has $76.27 Million Holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO)August 18, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Makes New Investment in BridgeBio Pharma, Inc. (NASDAQ:BBIO)August 18, 2025 | marketbeat.comVanguard Group Inc. Cuts Stock Position in BridgeBio Pharma, Inc. (NASDAQ:BBIO)August 16, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Hits New 1-Year High - Here's What HappenedAugust 15, 2025 | marketbeat.comBridgeBio Pharma, Inc. (NASDAQ:BBIO) Director Charles J. Homcy Sells 50,000 SharesAugust 14, 2025 | marketbeat.comCharles J. Homcy Sells 250,000 Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO) StockAugust 14, 2025 | marketbeat.comInformed Momentum Co LLC Takes $3.92 Million Position in BridgeBio Pharma, Inc. (NASDAQ:BBIO)August 13, 2025 | marketbeat.comBridgeBio Pharma, Inc. (NASDAQ:BBIO) Director Sells $2,400,000.00 in StockAugust 13, 2025 | insidertrades.comLeerink Partners Remains a Buy on BridgeBio Pharma (BBIO)August 12, 2025 | theglobeandmail.comBridgeBio Pharma, Inc. (NASDAQ:BBIO) CAO Maricel Apuli Sells 1,000 SharesAugust 12, 2025 | marketbeat.comInsider Selling: BridgeBio Pharma, Inc. (NASDAQ:BBIO) CEO Sells 40,000 Shares of StockAugust 12, 2025 | marketbeat.comInsider Selling: BridgeBio Pharma, Inc. (NASDAQ:BBIO) CAO Sells 1,000 Shares of StockAugust 12, 2025 | insidertrades.comBridgeBio Pharma, Inc. (NASDAQ:BBIO) Shares Sold by Cary Street Partners Financial LLCAugust 11, 2025 | marketbeat.comBank of America Securities Sticks to Their Buy Rating for BridgeBio Pharma (BBIO)August 11, 2025 | theglobeandmail.comBridgeBio Pharma (BBIO) Receives a Buy from Truist FinancialAugust 11, 2025 | theglobeandmail.comBridgeBio Pharma, Inc. (NASDAQ:BBIO) Shares Sold by Covestor LtdAugust 10, 2025 | marketbeat.comCetera Investment Advisers Has $1.78 Million Stock Holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO)August 10, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Upgraded to "Hold" at Wall Street ZenAugust 10, 2025 | marketbeat.comCantor Fitzgerald Has Positive View of BBIO FY2025 EarningsAugust 9, 2025 | marketbeat.comLeerink Partnrs Predicts Lower Earnings for BridgeBio PharmaAugust 9, 2025 | marketbeat.comBridgeBio Pharma, Inc. (BBIO) Q2 2025 Earnings Call TranscriptAugust 9, 2025 | seekingalpha.comCommerce Bank Invests $209,000 in BridgeBio Pharma, Inc. (NASDAQ:BBIO)August 9, 2025 | marketbeat.comInsider Selling: BridgeBio Pharma, Inc. (NASDAQ:BBIO) Director Sells 17,167 Shares of StockAugust 8, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Price Target Raised to $57.00 at ScotiabankAugust 7, 2025 | marketbeat.comTraders Purchase High Volume of Put Options on BridgeBio Pharma (NASDAQ:BBIO)August 7, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Shares Gap Down Following Weak EarningsAugust 7, 2025 | marketbeat.comOppenheimer Increases BridgeBio Pharma (NASDAQ:BBIO) Price Target to $61.00August 7, 2025 | marketbeat.comBridgeBio Pharma, Inc. (NASDAQ:BBIO) Shares Acquired by Mackenzie Financial CorpAugust 7, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Posts Quarterly Earnings Results, Misses Estimates By $0.45 EPSAugust 6, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Hits New 52-Week High - Should You Buy?August 6, 2025 | marketbeat.comBridgeBio Reports Second Quarter 2025 Financial Results and Business UpdatesAugust 5, 2025 | globenewswire.com Get BridgeBio Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for BBIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BBIO Media Mentions By Week BBIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BBIO News Sentiment▼0.790.97▲Average Medical News Sentiment BBIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BBIO Articles This Week▼1510▲BBIO Articles Average Week Get the Latest News and Ratings for BBIO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for BridgeBio Pharma and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies BeOne Medicines News Insmed News BioNTech News Teva Pharmaceutical Industries News Summit Therapeutics News Genmab A/S News Viatris News Dr. Reddy's Laboratories News Ascendis Pharma A/S News QIAGEN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BBIO) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BridgeBio Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BridgeBio Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access